Document:

Letter Agreement

 EXHIBIT 10.28 
 April 15, 2010 
 Mr. Mitchell Levinson 

Dear Mitch: 
 It is with great
pleasure that we extend this letter agreement to you to reflect your new role as Founder & Chief Scientific Officer of Zeltiq Aesthetics, Inc. (the “Company”) effective as of September 14, 2009. This letter summarizes the
terms and conditions of your ongoing employment. 
  

			
	Job Title:	  	Your title will be Founder & Chief Scientific Officer.
		
	Salary:	  	As of January 1, 2010 (the “Effective Date”), your monthly base salary will be $25,833.40 which is equivalent to $310,000 per annum. Your total compensation will be
reviewed at least annually by the Chief Executive Officer of the Company. All payments made in connection with your employment will be subject to applicable withholding taxes required by law.
		
	Stock Options:	  	The Company has previously granted you options to purchase an aggregate of 2,425,050 shares of Company Common Stock under the Company’s 2005 Stock Option Plan, as may be
amended from time to time (the “Plan”). The options are subject to the terms and conditions of the Plan and all related documents evidencing such options. Any shares of Company Common Stock received upon exercise of stock options granted
to you under the Plan are subject to the terms of the Right of First Refusal & Co-Sale Agreement entered into between the Company and certain of its holders of Common Stock and Preferred Stock.
		
	Promissory Note:	  	You and the Company entered into those certain Restricted Stock Purchase Agreements, dated as of December 11, 2007, whereby you exercised options to purchase an aggregate of
1,635,050 shares of the Company’s Common Stock for an aggregate purchase price of $245,257.55, which you paid by entering into promissory notes with the Company for an aggregate principal amount of $245,257.55 and interest on the unpaid
principal balance at a rate of 4.72% compounded annually (the “Notes”). Upon the Effective Date, you and the Company agree that the Notes shall be deemed amended to the extent necessary to provide that the principal amount of the Notes, as
well as all accrued but unpaid interest, will be due and payable on the first to occur of (i) a Change of Control;

			
		  	(ii) the fifth anniversary of the Effective Date; (iii) immediately prior to the filing by the Company of a registration statement covering securities of the Company with the
Securities and Exchange Commission under the Securities Act of 1933, as amended, or (iv) immediately prior to the Note becoming prohibited under Section 13(k) of the Securities Exchange Act of 1934, as amended. In addition, the interest rate of the
Notes shall be amended to be 4% per annum effective as of the Effective Date. You acknowledge that this reduction may have adverse tax consequences for you.
		
		  	For purposes of this letter, “Change of Control” means (1) a sale of all or substantially all of the Company’s assets, or (2) any merger, consolidation or other
business combination transaction of the Company with or into another corporation, entity or person, other than a transaction in which the holders of at least a majority of the shares of voting capital stock of the Company outstanding immediately
prior to such transaction continue to hold (either by such shares remaining outstanding or by their being converted into shares of voting capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting
capital stock of the Company (or the surviving entity) outstanding immediately after such transaction other than any transaction involving the issuance of any newly issued equity securities solely for cash.
		
	Obligations:	  	You agree to the best of your ability and experience that you will at all times faithfully perform all of the duties and obligations required of and from you, consistent and
commensurate with your position with the Company, pursuant to the terms hereof and to the reasonable satisfaction of the Chief Executive Officer of the Company. During the term of your employment relationship with the Company, you agree that you
will devote all of your business time and attention to the business of the Company, that the Company will be entitled to all of the benefits and profits arising from or incident to your work services and advice, that you will not render commercial
or professional services of any nature to any person or organization whether or not for compensation, without the prior written consent of the Chief Executive Officer of the Company and that you will not directly or indirectly engage or participate
in any business that is competitive in any manner with the business of the Company as currently conducted or proposed to be conducted, as a director, officer, advisor, employee, consultant or contractor or in any other capacity with respect to any
such competitive business, or by making an investment in any such competitive business. Nothing in this letter agreement will prevent you from accepting speaking or presentation engagements
in

  
 2 

			
		  	exchange for honoraria or – subject to the prior written consent of the Chief Executive Officer of the Company – from serving on boards of non-competitive
organizations, or from owning no more than 1% of the outstanding equity securities of a corporation whose stock is listed on a national stock exchange, provided that such activities do not materially interfere with your obligations to the Company as
described above. You agree that you will comply with and be bound by the Company’s operating policies, procedures and practices from time to time in effect during the term of your employment relationship with the Company.
		
	Acceleration:	  	In the event that (i) in connection with, six (6) months prior to, or at any time following a Change of Control, your employment is terminated by the Company or the surviving
entity, as applicable, without “Cause” (for purposes of this “Acceleration” section only, as defined in the Company’s 2005 Stock Option Plan, as amended) or you terminate your employment as a result of a Constructive
Termination (as defined below) or (ii) subject to your continued employment with the Company or any successor, six (6) months elapse from the closing date of a Change of Control, then the vesting of any stock options held by you at the time of such
event or the lapsing of any repurchase option held by the Company at the time of such event with respect to restricted stock or shares purchased by you upon the exercise of any stock options prior to the time such stock options are vested (the
“Repurchase Option”) shall automatically be accelerated by 100% of the number of shares subject to the option or Repurchase Option so that all such shares are vested and exercisable and, if applicable, released from the Repurchase
Option as of immediately prior to the later of the Change of Control or the date of the event giving rise to such acceleration. The agreements evidencing any stock options, restricted stock and other equity awards outstanding shall he deemed amended
and any provisions of any future agreements superseded to the extent necessary to give effect to this paragraph, including, without limitation, extending the date upon which any portion of an option terminates until the date that is six (6) months
following the date you terminate employment with the Company (or, if later, the date such option terminates under the “Termination” section below), extending any Repurchase Option until the date that is nine (9) months following the date
you terminate employment with the Company and, with respect to an option which is accelerated following your termination, providing that such option shall be exercisable during the three (3) month period following the Change of Control (or such
longer period provided under the “Termination” section below). Notwithstanding anything in this paragraph to the contrary, in no event shall the exercise period of an option be extended beyond the expiration date of such
option.

  
 3 

			
	Benefits:	  	During your employment, you will be fully eligible for all benefits offered by the Company from time to time, subject to plan terms and generally applicable Company policies.
Subject to change, the Company currently plans to include major group medical, dental and vision care insurance, life insurance and a 401K savings program. A full description of these benefits is available upon request.
		
	Paid Time Off:	  	In addition to the Company’s annual holiday schedule, your paid time off allowance will be 21 days per year, which includes vacation and sick leave. This allowance is
subject to the Company’s policies with respect to accrual of paid time off, including limitations on the maximum permitted accrual of, paid time off and is subject to change in accordance with changes in Company policy, provided that your
benefits following such changes will be no less favorable than those available to other members of the Company’s senior management.
		
	Termination:	  	Your employment will continue until terminated by you or the Company in accordance with the following.
		
		  	 (a)    Without Cause Termination. If your employment with the Company is terminated by the Company
without Cause or if you terminate your employment as the result of a Constructive Termination, and, in each case, such termination constitutes a “separation from service” within the meaning of Section 409A of the Internal Revenue Code
of 1986, as amended (the “Code”), and the Department of Treasury regulations and other guidance promulgated thereunder (a “Separation from Service”), then provided within sixty (60) days of such termination, you sign, and
fail to revoke during any applicable revocation period, a general release of claims with respect to the Company or its successor, the obligations of the Company to you will be as follows:

		
		  	 (i)     Severance Payment. For the six (6) month period commencing sixty (60) days
following such Separation from Service (the “Severance Period ), you will be entitled to receive as severance an amount equal to six (6) months of your base salary as then in effect paid periodically in accordance with the Company’s
standard compensation schedule. If you experience a Separation from Service as a result of your death or Disability (defined as a physical or mental impairment

  
 4 

			
		  	 which renders you unable to fulfill all of the essential functions of your job for 180 consecutive days in any calendar year), such Separation from
Service shall be considered a termination without Cause under this Agreement. In the event of a Disability, the payments due to you by the Company during the Severance Period will be reduced by any payments made to you during the Severance Period
under any Company-paid disability insurance policy.

		
		  	 (ii)    Benefits. Commencing on the date of your Separation from Service and continuing through the
earlier of six (6) month anniversary of your Separation from Service or the date you are no longer eligible for coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), the Company will reimburse you for
any premium costs paid by you for continued health insurance coverage (including medical and dental) for you and your eligible dependents under COBRA.

		
		  	 (iii)  Vesting of Stock. Subject to the terms set forth in the “Acceleration” section to the extent
they are applicable as a result of a Change of Control (and the terms of such “Acceleration” section shall apply in lieu of the provisions of this sentence in the event of a Change of Control), following the date of your Separation from
Service, the vesting of each stock option, restricted stock award and other equity award then held by you shall continue during the 24-month period following your Separation from Service as though you remain employed hereunder, provided, that
during such 24-month period if any act, or failure to act, by you would, if you were still employed hereunder, constitute Cause (as defined below), then your stock options, restricted stock awards and other stock awards shall immediately cease
vesting. Upon the second anniversary of the date of your Separation of Service, in the event no act, or failure to act, by you prior to such date would have constituted Cause had you remained employed hereunder, then all remaining unvested stock
options, restricted stock awards or other equity awards then held by you shall accelerate and any restrictions thereon shall lapse. Further, the exercise period for the vested shares subject to each option held by you will be extended to the earlier
of the expiration date of such option or 5 years following the date you experience

  
 5 

			
		  	 such Separation from Service; provided, however, that such options will be Nonstatutory Stock Options (as defined in the Plan) to the extent
required by law, including, without limitation, to the extent unexercised three months after the date of your termination from employment.

		
		  	 (b)    For Cause Termination; Voluntary Resignation. (1) If your employment with the Company
is terminated by the Company for Cause; or (2) you voluntarily resign your service with the Company other than as a Constructive Termination; the obligations of the Company to you will be as follows:

		
		  	 (i)     Compensation. You will be entitled to receive your base salary through the date of
termination, including any accrued vacation to that date.

		
		  	 (ii)    Benefits. Your entitlement to benefits will cease, except as otherwise required by COBRA or
any similar law or regulation then in effect.

		
		  	 (iii)  Vesting of Stock. There will be no further vesting of any shares of any class of stock of the Company
that you hold as of the termination.

		
		  	 (c)    Certain Definitions. The following terms have the definitions
indicated:

		
		  	 (i)     As used in this “Termination” section, “Cause” means (A) the
termination of your employment as the result of your conviction of or plea of no contest to a felony, (B) any act of dishonesty by you involving the Company that materially damages the Company or any of its affiliates, or (C) a material
breach by you of the terms of (1) any non-competition, non-solicitation, or invention assignment obligation you have to the Company (2) the Confidential Information and Inventions Assignment Agreement entered into between you and the
Company as of July 25, 2005, or (3) your obligations under this letter agreement, including, without limitation, those described under the section Obligations” or (D) a willful, material breach by you of the terms of any
non-disclosure obligation you owe to the Company.

  
 6 

			
		  	 (ii)    As used in this “Termination” section and the “Acceleration” section,
“Constructive Termination” means (w) a material diminution in your job responsibilities or duties, (x) a breach of this agreement by the Company which is not cured by the Company not later than thirty (30) days from the date
of receipt by the Company of a written notice from you identifying in reasonable detail such breach, (y) a reduction in your compensation that is not proportionately applicable to other officers generally, or (z) the relocation of the
Company’s principal office beyond a radius of 25 miles from its current location, in any case unless otherwise approved by you in writing. Notwithstanding the foregoing, you shall be deemed to have experienced a Constructive Termination upon
Separation from Service from the Company that occurs after September 14, 2010.

		
	Other:	  	Company Policies and Rules. You will abide by all Company policies and rules, especially its policy that prohibits any new employee from using or bringing with them from
any prior employer or any other person or entity any confidential information, trade secrets or proprietary materials or processes of that employer or other person or entity.
		
		  	At-Will Employment. Your employment at the Company is “At Will,” meaning it is not for a specific term and can be terminated by you or by the Company at any time
for any reason, with or without cause. If your employment terminates for any reason, you shall not be entitled to any payments, benefits, damages award or compensation other than as expressly provided in the sections entitled
“Acceleration” and “Termination” set forth above.
		
		  	No Conflicting Obligations. You hereby acknowledge that you are not a party to any agreement that in any way prohibits or imposes any restrictions on your employment with
the Company, and your acceptance hereof will not breach any agreement to which you are a party.
		
		  	Arbitration. Any dispute or controversy between you and the Company concerning the application of this agreement or arising from or as a result of your recruitment,
employment or employment termination, including any claims of discrimination or other claims under any federal, state, or local law shall be resolved, after the Parties attempt informal resolution, through arbitration before a single arbitrator
selected by the parties in accordance with the JAMS Employment Arbitration Rules and Procedures, to be administered by JAMS/Endispute. Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The
Company shall bear all costs unique to arbitration, including arbitrator’s fees. At the conclusion of arbitration, the arbitrator shall issue an award in writing setting forth the basis for the
award.

  
 7 

			
		  	Section 409A. For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)),
Executive’s right to receive the installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and
distinct payment.
		
		  	Entire Agreement. Once signed by you, this letter will become a legally binding contract. It will constitute our complete agreement, and will supersede all prior
agreements, promises, and discussions. This agreement may only be amended or modified in a subsequent written document signed by the Chief Executive Officer of the Company or a duly-authorized member of the Board of Directors.

 Mitch, we continue to be excited about the Company’s opportunities and look forward to working
together to advance Zeltiq Aesthetics, Inc. to the next level. If you have any questions regarding this letter, please do not hesitate to call. If you are in agreement with its terms, please countersign the enclosed copy of this letter and return to
me at your earliest convenience. 
  

	
	Sincerely,
	
	/s/ Gordie Nye
	 Gordie Nye
 Chief Executive
Officer
 Zeltiq Aesthetics, Inc.

 Foregoing terms and modifications hereby accepted: 

									
					
	 Signed:
	 	/s/ Mitchell Levinson	 		 	Dated:	 	4/21/10                
		 	Mitchell Levinson	 		 		 	

  
 8Offer Letter Agreement

 EXHIBIT 10.29 
 [ZELTIQ Logo] 
 November 20, 2009 
 Joshua Brumm 
 Re: EMPLOYEE OFFER
LETTER 
 Dear Josh: 
 ZELTIQ AESTHETICS, INC. (the “Company”) is pleased to offer you the position of Director of Business Development and Strategy reporting to
John Howe, Chief Financial Officer. You will perform duties customarily associated with your position and such other duties as may be assigned by the Chief Financial Officer, the Chief Executive Officer of the Company, or his or her designate. By
signing this letter agreement, you represent and warrant to the Company that you are under no contractual commitments inconsistent with your obligations to the Company. 
 1. COMPENSATION. 
  

	 	(a)	Base Salary. You will be paid a base salary at the annual rate of $165,000, payable in semi-monthly installments or otherwise in accordance with the
Company’s standard payroll practices for salaried employees (“Base Salary”). The Base Salary may be adjusted pursuant to the Company’s employee compensation policies in effect from time to time. 

 

	 	(b)	2010 Incentive Bonus. In addition to your base salary, you will be eligible to receive an annualized bonus of $45,000 payable in quarterly increments
effective January 1, 2010. Receipt of the incremental bonus will be based upon the achievement of the 2010 International Sales Plan, which will be finalized by December 2009. 

 

	 	(c)	Signing Bonus. In addition to your Base Salary, you will receive a one time Signing Bonus in the amount of $32,000 (less all applicable taxes) to be paid
within two weeks of your start date. If your employment is terminated voluntarily or for cause within 90 days of your start date you will be required to repay this amount to the Company. 

 

	 	(d)	Stock Options. Company’s management will recommend to the Company’s Board of Directors that you be granted an option (the “Stock
Option”) to purchase 40,000 shares of the Company’s Common Stock. The exercise price per share will be equal to the fair market value per share on the date the option is granted or on your first day of employment, whichever is later. The
Stock Option shall vest over four (4) years with one-fourth (1/4) of the options vesting at the end of twelve (12) months, and the remainder vesting monthly at a rate of 1/48th of the total number per month thereafter until all shares
are vested. The Stock Option shall be an incentive stock option to the extent permitted by applicable law. The Stock Option will be subject to the terms and conditions applicable to options granted under the Company’s 2005 Equity Incentive
Plan, and as described in that plan and the applicable stock option agreement. 

  
 1 

 2. BENEFITS. You shall be entitled to the
Company’s basic employment benefits available to all similarly-situated Company employees, as the same currently exist or may exist in the future. You acknowledge that participation in Company benefit programs may require payroll deductions
and/or direct contributions by you. 
 3. EMPLOYMENT TERMS. Your employment
relationship with the Company will continue to be governed by the general employment policies and practices of the Company. You will be required as a condition of employment with the Company, to (i) acknowledge your receipt and understanding,
sign and abide by the Company’s standard Confidential Information and Invention Assignment Agreement, attached hereto as Appendix B; (ii) sign and return a satisfactory 1-9 Immigration form providing sufficient documentation
establishing your employment eligibility in the United States, and (iii) provide satisfactory proof of your identity as required by United States law. Your duties under the Confidential Information and Invention Assignment Agreement shall
survive termination of your employment with the Company. By signing this letter, you acknowledge that a remedy at law for any breach or threatened breach by you of the provisions of the Confidential Information and Invention Assignment Agreement
would be inadequate, and you therefore agree that the Company shall be entitled to injunctive relief in case of any such breach or threatened breach. 
 4. AT-WILL EMPLOYMENT. Your employment with the Company will still be “at-will,” meaning that either you or the Company will be
entitled to terminate your employment at any time and for any or no reason, with or without cause. Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to
time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the Company. Your participation in any stock purchase or benefit program is not to be regarded
as assuring you continuing employment for any particular period of time. 
 5. OUTSIDE
ACTIVITIES. While you render services to the Company, you will not engage in any other gainful employment, business or activity without the written consent of the Company. While you render services to the Company,
you also will not assist any person or organization in competing with the Company, in preparing to compete with the Company, or in hiring any employees of the Company. During the term of your employment by the Company, except on behalf of the
Company, you shall not directly or indirectly, whether as an officer, director, stockholder, partner, proprietor, associate, representative, consultant, or in any capacity whatsoever engage in, become financially interested in, be employed by or
have any business connection with any other person, corporation, firm, partnership or other entity whatsoever which were known by you to compete directly with the Company, throughout the world, in any line of business engaged in (or planned to be
engaged in) by the Company; provided, however, that anything above to the contrary notwithstanding, you may own, as a passive investor, securities of any competitor corporation, so long as your direct holdings in any one such corporation shall not
in the aggregate constitute more than 1% of the voting stock of such corporation. 
 6. SATISFACTORY
REFERENCE CHECKS. This offer is contingent upon completion of professional reference checks by the Company, at its discretion and to its satisfaction. 

7. START DATE. Your start date shall be on December 9th, 2009. This offer, if
not accepted, will expire at the close of business on November 23, 2009. 
 8. ENTIRE
AGREEMENT. This offer letter sets forth the full and complete agreement between you and the Company regarding your employment with the Company. Any additional or contrary terms, representations, offers or
agreements, whether written or oral, that may have been made to you are hereby revoked and superseded in their entirety by this offer. 

  
 2 

 We hope that you find the foregoing terms acceptable. You may indicate your agreement with
these terms and accept this offer by signing and dating both the enclosed duplicate original of this letter and the enclosed Confidential Information and Invention Assignment Agreement and returning them to me. 

If you have any questions, please call John Howe at 925-474-2573. 

Very truly yours, 

	
	
	/s/ John Howe
	JOHN HOWE
	CHIEF FINANCIAL OFFICER

 AGREED AND ACCEPTED 
 I have read and accept this employment offer: 

	
	
	/s/ Joshua Brumm
	Joshua Brumm
	Dated: 11/12/09

  
 3 

 Appendix B 
 Confidential Information and Invention Assignment Agreement 
 As a
condition of my becoming employed (or my employment being continued) or retained as a consultant (or my consulting relationship being continued) by Zeltiq Aesthetics, Inc., a Delaware corporation, with any of its current or future subsidiaries,
affiliates, successors or assigns (collectively, the “Company”), and in consideration of my employment or consulting relationship with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I
agree to the following: 
 1. Employment or Consulting Relationship. I understand and acknowledge that this
Agreement does not alter, amend or expand upon any rights I may have to continue in the employ of, or in a consulting relationship with, or the duration of my employment or consulting relationship with, the Company under any existing agreements
between the Company and me or under applicable law. Any employment or consulting relationship between the Company and me, whether commenced prior to or upon the date of this Agreement, shall be referred to herein as the “Relationship.”

 2. At-Will Employment. I understand and acknowledge that my Relationship with the Company is and shall continue
to be at-will, as defined under applicable law, meaning that either I or the Company may terminate the Relationship at any time for any reason or no reason, without further obligation or liability. 

3. Confidential Information. 
 (a) Company Information. I agree at all times during the term of my Relationship with the Company and thereafter, to hold in strictest confidence, and not to use, except for the benefit of
the Company, or to disclose to any person, firm, corporation or other entity without written authorization of the Board of Directors of the Company, any Confidential Information of the Company which I obtain or create. I further agree not to make
copies of such Confidential Information except as authorized by the Company. I understand that “Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not
limited to, research, product plans, products, services, suppliers, customer lists and customers (including, but not limited to, customers of the Company on whom I called or with whom I became acquainted during the Relationship), prices and costs,
markets, software, developments, inventions, laboratory notebooks, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, licenses, finances, budgets or other business information disclosed to
me by the Company either directly or indirectly in writing, orally or by drawings or observation of parts or equipment or created by me during the period of the Relationship, whether or not during working hours, and any information pertaining to any
aspects of the Company’s business which is either information not known by actual or potential competitors of the Company or is proprietary information of the Company or its customers or suppliers, whether of a technical nature or otherwise. I
further understand that Confidential Information does not include any of the foregoing items which has become publicly and widely known and made generally available through no wrongful act of mine or of others who were under confidentiality
obligations as to the item or items involved. 
 (b) Former Employer Information. I represent that
my performance of all terms of this Agreement as an employee or consultant of the Company have not breached and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or trust
prior or subsequent to the commencement of my Relationship with the Company, and I will not disclose to the Company, or induce the Company to use, any inventions, confidential or proprietary information or material belonging to any previous employer
or any other party. 

 (c) Third Party Information. I recognize that the Company has
received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited
purposes. I agree to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work for the Company consistent with
the Company’s agreement with such third party. 
 4. Inventions. 

(a) Inventions Retained and Licensed. I have attached hereto, as Exhibit A, a list describing with
particularity all inventions, original works of authorship, developments, improvements, and trade secrets which were made by me prior to the commencement of the Relationship (collectively referred to as “Prior Inventions”), which
belong solely to me or belong to me jointly with another, which relate in any way to any of the Company’s proposed businesses, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is
attached, I represent that there are no such Prior Inventions. If, in the course of my Relationship with the Company, I incorporate into a Company product, process or machine a Prior Invention owned by me or in which I have an interest, the Company
is hereby granted and shall have a non-exclusive, royalty-free, irrevocable, perpetual, worldwide license (with the right to sublicense) to make, have made, copy, modify, make derivative works of, use, sell and otherwise distribute such Prior
Invention as part of or in connection with such product, process or machine. 
 (b) Assignment of
Inventions. I agree that I will promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title and interest
throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, improvements or trade secrets, whether or not patentable or registrable under copyright or similar laws, which I may solely or
jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of time in which I am employed by or a consultant of the Company (collectively referred to as
“Inventions”), except as provided in Section 4(e) below. I further acknowledge that-all inventions, original works of authorship, developments, concepts, know-how, improvements or trade secrets which are made by me (solely or
jointly with others) within the scope of and during the period of my Relationship with the Company are “works made for hire” (to the greatest extent permitted by applicable law) and are compensated by my salary (if I am an employee)
or by such amounts paid to me under any applicable consulting agreement or consulting arrangements (if I am a consultant), unless regulated otherwise by the mandatory law of the state of California. 

(c) Maintenance of Records. I agree to keep and maintain adequate and current written records of all
Inventions made by me (solely or jointly with others) during the term of my Relationship with the Company. The records may be in the form of notes, sketches, drawings, flow charts, electronic data or recordings, laboratory notebooks, and any other
format. The records will be available to and remain the sole property of the Company at all times. I agree not to remove such records from the Company’s place of business except as expressly permitted by Company policy which may, from time to
time, be revised at the sole election of the Company for the purpose of furthering the Company’s business. 

(d) Patent and Copyright Rights. I agree to assist the Company, or its designee, at the Company’s
expense, in every proper way to secure the Company’s rights in the Inventions and any copyrights, patents, trademarks, mask work rights, moral rights, or other intellectual property rights relating thereto in any and all countries, including
the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, 

 
assignments, recordations, and all other instruments which the Company shall deem necessary in order to apply for, obtain, maintain and transfer such rights and in order to assign and convey to
the Company, its successors, assigns and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. I further agree that
my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after the termination of this Agreement until the expiration of the last such intellectual property right to expire in
any country of the world. If the Company is unable because of my mental or physical incapacity or unavailability or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or
copyright registrations covering Inventions or original works of authorship assigned to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact,
to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance or transfer of letters patent or copyright registrations
thereon with the same legal force and effect as if originally executed by me. I hereby waive and irrevocably quitclaim to the Company any and all claims, of any nature whatsoever, which I now or hereafter have for infringement of any and all
proprietary rights assigned to the Company. 
 (e) Exception to Assignments. I understand that the
provisions of this Agreement requiring assignment of Inventions to the Company do not apply to any invention which qualifies fully under the provisions of California Labor Code Section 2870 (attached hereto as Exhibit B). I will advise
the Company promptly in writing of any inventions that I believe meet such provisions and are not otherwise disclosed on Exhibit A. 
 5. Returning Company Documents. I agree that, at the time of termination of my Relationship with the Company, I will deliver to the Company (and will not keep in my possession, recreate or
deliver to anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, laboratory notebooks, materials, flow charts, equipment, other documents or property, or
reproductions of any aforementioned items developed by me pursuant to the Relationship or otherwise belonging to the Company, its successors or assigns. I further agree that to any property situated on the Company’s premises and owned by the
Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company personnel at any time with or without notice. In the event of the termination of the Relationship, I agree to sign and deliver
the “Termination Certification” attached hereto as Exhibit C. 
 6. Notification to Other
Parties. 
 (a) Employees. In the event that I leave the employ of the Company, I hereby
consent to notification by the Company to my new employer about my rights and obligations under this Agreement. 

(b) Consultants. I hereby grant consent to notification by the Company to any other parties besides the
Company with whom I maintain a consulting relationship, including parties with whom such relationship commences after the effective date of this Agreement, about my rights and obligations under this Agreement. 

7. Solicitation of Employees, Consultants and Other Parties. I agree that during the term of my Relationship with the
Company, and for a period of twelve (12) months immediately following the termination of my Relationship with the Company for any reason, whether with or without cause, I shall not either directly or indirectly solicit, induce, recruit or
encourage any of the Company’s employees or consultants to terminate their relationship with the Company, or take away such employees or consultants, 

 
or attempt to solicit, induce, recruit, encourage or take away employees or consultants of the Company, either for myself or for any other person or entity. Further, for a period of twelve
(12) months following termination of my Relationship with the Company for any reason, with or without cause, I shall not solicit any licensor to or customer of the Company or licensee of the Company’s products, in each case, that are known
to me, with respect to any business, products or services that are competitive to the products or services offered by the Company or under development as of the date of termination of my Relationship with the Company. 

8. Representations and Covenants. 
 (a) Facilitation of Agreement. I agree to execute promptly any proper oath or verify any proper document required to carry out the terms of this Agreement upon the Company’s written
request to do so. 
 (b) Conflicts. I represent that my performance of all the terms of this
Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to commencement of my Relationship with the Company. I have not entered into, and I agree I will not enter into, any
oral or written agreement in conflict with any of the provisions of this Agreement. 
 (c) Voluntary
Execution. I certify and acknowledge that I have carefully read all of the provisions of this Agreement and that I understand and will fully and faithfully comply with such provisions. 

9. General Provisions. 
 (a) Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California, without giving effect to the
principles of conflict of laws. 
 (b) Entire Agreement. This Agreement sets forth the entire
agreement and understanding between the Company and me relating to the subject matter herein and merges all prior discussions between us. No modification or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be
effective unless in writing signed by the party to be charged. Any subsequent change or changes in my duties, obligations, rights or compensation will not affect the validity or scope of this Agreement. 

(c) Severability. If one or more of the provisions in this Agreement are deemed void by law, then the
remaining provisions will continue in full force and effect. 
 (d) Successors and Assigns. This
Agreement will be binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 

(e) Survival. The provisions of this Agreement shall survive the termination of the Relationship and the
assignment of this Agreement by the Company to any successor in interest or other assignee. 
 (f) ADVICE
OF COUNSEL. I ACKNOWLEDGE THAT, IN EXECUTING THIS AGREEMENT, I HAVE HAD THE OPPORTUNITY TO SEEK THE ADVICE OF INDEPENDENT LEGAL COUNSEL, AND I HAVE READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL
NOT BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF. 
 [Signature Page Follows] 

 The parties have executed this Agreement on the respective dates set forth below:

  

									
	COMPANY:	 		 		 	EMPLOYEE:
				
	ZELTIQ AESTHETICS, INC.	 		 		 	JOSHUA BRUMM, an Individual:
				
	/s/ John Howe	 		 		 	/s/ Joshua T. Brumm
	Signature	 		 		 	Signature
					
	By:	 	John Howe	 		 		 	Joshua T. Brumm
	Title:	 	CFO	 		 		 	Printed Name
					
	Date:	 	11/20/09	 		 		 	Date: 11/22/09
				
	 Address: 4698 Willow Road
                 Pleasanton, CA 94588
	 		 		 	 Address: 

 EXHIBIT A 
 LIST OF PRIOR INVENTIONS 
 AND ORIGINAL WORKS OF AUTHORSHIP

 EXCLUDED FROM SECTION 4 
  

					
	 Title
	 	 Date
	 	 Identifying Number
or Brief Description

x No inventions or improvements 
  ̈ Additional Sheets Attached 

			
		
	Signature of Employee/Consultant:	 	/s/ Joshua T. Brumm
		
	Print Name of Employee/Consultant:	 	Joshua T. Brumm

 Date: 11/22/09 

 EXHIBIT B 
 Section 2870 of the California Labor Code is as follows: 
 (a) Any provision
in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time
without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either: 
 (1) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or

 (2) Result from any work performed by the employee for the employer. 

(b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from
being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable. 

 EXHIBIT C 
 TERMINATION CERTIFICATION 
 This is to certify that I do not have in my
possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, laboratory notebooks, flow charts, materials, equipment, other documents or
property, or copies or reproductions of any aforementioned items belonging to Zeltiq Aesthetics, Inc., its subsidiaries, affiliates, successors or assigns (together the “Company”). 

I further certify that I have complied with all the terms of the Company’s Confidential Information and Invention Assignment
Agreement signed by me, including the reporting of any inventions and original works of authorship (as defined therein), conceived or made by me (solely or jointly with others) covered by that agreement. 

I further agree that, in compliance with the Confidential Information and Invention Assignment Agreement, I will preserve as confidential
all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, data bases, other original works of authorship,
customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants or licensees. 

I further agree that for twelve (12) months from the date of this Certificate, I shall not either directly or indirectly solicit,
induce, recruit or encourage any of the Company’s employees or consultants to terminate their relationship with the Company, or take away such employees or consultants, or attempt to solicit, induce, recruit, encourage or take away employees or
consultants of the Company, either for myself or for any other person or entity. Further, for a period of twelve (12) months from the date of this Certificate, I shall not solicit any licensor to or customer of the Company or licensee of the
Company’s products, in each case, that are known to me, with respect to any business, products or services that are competitive to the products or services offered by the Company or under development as of the date of termination of my
Relationship with the Company. 
  

					
	Date: 11/22/09	 		 	/s/ Joshua T. Brumm
		 		 	(Employee’s Signature)
			
	 	 		 	Joshua T. Brumm
		 		 	(Type/Print Employee’s Name)

  
 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]